Lycopene Promotes Osteogenesis and Reduces Adipogenesis through Regulating FoxO1/PPARγ Signaling in Ovariectomized Rats and Bone Marrow Mesenchymal Stem Cells
Nutrients · 2024
DOI: 10.3390/nu16101443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Bingke Xia und 16 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Center, Traditional Chinese Medicine School, Beijing University of Chinese Medicine, Beijing 100029, China. Hauptthemen laut MEDLINE: Adipogenesis, Lycopene, Mesenchymal Stem Cells, Osteogenesis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Public Welfare Research Institutes.
Abstract (Originalsprache)
Recent interest in preventing the development of osteoporosis has focused on the regulation of redox homeostasis. However, the action of lycopene (LYC), a strong natural antioxidant compound, on osteoporotic bone loss remains largely unknown. Here, we show that oral administration of LYC to OVX rats for 12 weeks reduced body weight gain, improved lipid metabolism, and preserved bone quality. In addition, LYC treatment inhibited ROS overgeneration in serum and bone marrow in OVX rats, and in BMSCs upon H2O2 stimulation, leading to inhibiting adipogenesis and promoting osteogenesis during bone remodeling. At the molecular level, LYC improved bone quality via an increase in the expressions of FoxO1 and Runx2 and a decrease in the expressions of PPARγ and C/EBPα in OVX rats and BMSCs. Collectively, these findings suggest that LYC attenuates osteoporotic bone loss through promoting osteogenesis and inhibiting adipogenesis via regulation of the FoxO1/PPARγ pathway driven by oxidative stress, presenting a novel strategy for osteoporosis management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diabetes Research Center, Traditional Chinese Medicine School, Beijing University of Chinese Medicine, Beijing 100029, China.
- Food and Pharmacy College, Xuchang University, 88 Bayi Road, Xuchang 461000, China.
- The Scientific Research Center, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China.
- Department of Pharmacology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450003, China.
- Department of TCM Pharmacology, Chinese Material Medica School, Beijing University of Chinese Medicine, Beijing 102488, China.
- Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
ORCID-Profile: Ruyuan Zhu, Dongwei Zhang
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Public Welfare Research Institutes
Zitieren
APA
Xia, B., Dai, X., Shi, H., Yin, J., Xu, T., Liu, T., Yue, G., Guo, H., Liang, R., Liu, Y., Gao, J., Wang, X., Chen, X., Tang, J., Wang, L., Zhu, R., & Zhang, D. (2024). Lycopene Promotes Osteogenesis and Reduces Adipogenesis through Regulating FoxO1/PPARγ Signaling in Ovariectomized Rats and Bone Marrow Mesenchymal Stem Cells. Nutrients. https://doi.org/10.3390/nu16101443
Vancouver
Xia B, Dai X, Shi H, Yin J, Xu T, Liu T, et al. Lycopene Promotes Osteogenesis and Reduces Adipogenesis through Regulating FoxO1/PPARγ Signaling in Ovariectomized Rats and Bone Marrow Mesenchymal Stem Cells. Nutrients. 2024. doi:10.3390/nu16101443
BibTeX
@article{Xia2024,
author = {Xia, Bingke and Dai, Xuan and Shi, Hanfen and Yin, Jiyuan and Xu, Tianshu and Liu, Tianyuan and Yue, Gaiyue and Guo, Haochen and Liang, Ruiqiong and Liu, Yage and Gao, Junfeng and Wang, Xinxiang and Chen, Xiaofei and Tang, Jinfa and Wang, Lili and Zhu, Ruyuan and Zhang, Dongwei},
title = {Lycopene Promotes Osteogenesis and Reduces Adipogenesis through Regulating FoxO1/PPARγ Signaling in Ovariectomized Rats and Bone Marrow Mesenchymal Stem Cells},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16101443}
}
EUVIMED